Driehaus Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-63,000
Closed -$6.26M 632
2019
Q3
$6.26M Hold
63,000
0.2% 130
2019
Q2
$5.82M Buy
63,000
+16,572
+36% +$1.57M 0.18% 145
2019
Q1
$4.38M Buy
+46,428
New +$4.06M 0.16% 149
2017
Q2
Sell
-5,829
Closed -$725K 718
2017
Q1
$725K Buy
+5,829
New +$698K 0.02% 401
2016
Q3
Sell
-29,448
Closed -$2.9M 688
2016
Q2
$2.9M Sell
29,448
-3,389
-10% -$351K 0.1% 200
2016
Q1
$3.29M Buy
32,837
+2,595
+9% +$267K 0.11% 195
2015
Q4
$3.62M Buy
30,242
+4,896
+19% +$566K 0.12% 188
2015
Q3
$2.74M Sell
25,346
-2,518
-9% -$312K 0.1% 221
2015
Q2
$3.23M Sell
27,864
-167
-0.6% -$19.1K 0.11% 233
2015
Q1
$3.23M Buy
28,031
+4,309
+18% +$515K 0.11% 232
2014
Q4
$2.65M Sell
23,722
-12,538
-35% -$1.32M 0.11% 249
2014
Q3
$3.44M Sell
36,260
-60,429
-62% -$5.45M 0.13% 210
2014
Q2
$8.3M Sell
96,689
-4,927
-5% -$375K 0.27% 93
2014
Q1
$7.09M Buy
101,616
+18,458
+22% +$1.46M 0.22% 127
2013
Q4
$7.03M Buy
83,158
+43,740
+111% +$3.46M 0.25% 121
2013
Q3
$3.03M Buy
+39,418
New +$2.76M 0.12% 229

Other funds holding CELG

Driehaus Capital Management's CELG Position: Q4 2019 in Review

Driehaus Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 63,000 shares — an estimated $6.26M sold.

Driehaus Capital Management first reported a position in CELG in Q3 2013 and held it in 16 quarters. The position peaked at $8.3M in Q2 2014. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Driehaus Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Driehaus Capital Management sold 63,000 Celgene Corp shares in Q4 2019, an estimated $6.26M.
  • Driehaus Capital Management first reported a position in Celgene Corp in Q3 2013 and held it in 16 quarters.
  • Driehaus Capital Management's Celgene Corp position peaked at $8.3M in Q2 2014.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Driehaus Capital Management's 13F filing for Q4 2019, filed 12 Feb 2020.